Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis-Reference-Cited by-同舟云学术

Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis

Published:2005-05 Issue:5 Volume:4 Page:281-288
ISSN:1474-4422
Container-title:The Lancet Neurology
language:en
Short-container-title:The Lancet Neurology

Author:

Miller David,Barkhof Frederik,Montalban Xavier,Thompson Alan,Filippi Massimo

Publisher

Elsevier BV

Subject

Neurology (clinical)

Reference69 articles.

1. Relapses and progression of disability in multiple sclerosis;Confavreux;N Engl J Med,2000

2. Early clinical predictors and progression of irreversible disability in multiple sclerosis: an amnesic process;Confavreux;Brain,2003

3. Nilsson P, Larsson E-M, Maly-Sundgren P, Perfekt R, Sandberg-Wollheim M. Predicting the outcome of optic neuritis—evaluation of risk factors after 30 years of follow up. J Neurol (in press).

4. Effect of early interferon treatment on conversion to definite multiple sclerosis;Comi;Lancet,2001

5. Long-term follow-up of patients with clinically isolated syndromes, relapsing remitting and secondary progressive multiple sclerosis;Eriksson;Mult Scler,2003

Cited by 472 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optic Nerve Imaging in Multiple Sclerosis and Related Disorders;Neuroimaging Clinics of North America;2024-08

2. Correlation of Visual System Biomarkers With Motor Deficits in Experimental Autoimmune Encephalomyelitis-Optic Neuritis;Translational Vision Science & Technology;2024-08-01

3. Disease Modifying Strategies in Multiple Sclerosis: New Rays of Hope to Combat Disability?;Current Neuropharmacology;2024-07

4. Multiple Sclerosis: Immune Cells, Histopathology, and Therapeutics;Sclerosis;2024-06-27

5. Real-World Effectiveness and Safety of Cladribine in Multiple Sclerosis: Longitudinal Data From the Nationwide Registry in Argentina;Clinical Neuropharmacology;2024-05-22